MULTI-COMPONENT DRUG DELIVERY OF PACLITAXEL
Journal Title: Journal of Drug Delivery and Therapeutics - Year 2017, Vol 7, Issue 3
Abstract
Co-delivery systems have been proved to be of much benefit to the anti-cancer drug field. In order to make these drugs successful, nano-particles usage has been promoted. The mini-review has brought forward some of the most prominent co-delivery developments in the field, especially with paclitaxel. The discussion here is never meant to be comprehensive, but to give some new trends and highlights within this area.
Authors and Affiliations
Zhengwei Zhang
Keywords
Related Articles
- EP ID EP295539
- DOI 10.22270/jddt.v7i3.1451
- Views 83
- Downloads 0
DEVELOPMENT AND EVALUATION OF PRONIOSOMES AS DRUG CARRIERS FOR TRANSDERMAL DELIVERY OF KETOROLAC TROMETHAMINE
Ketorolac tromethamine is a drug with narrow therapeutic index and short biological half-life. This study was aimed at developing and optimizing proniosomal formulation of ketorolac tromethamine in order to improve its b...
EXPLORING PHYTOCHEMICALS AND PHARMACOLOGICAL USES OF CORDIA DICHOTOMA (INDIAN CHERRY): A REVIEW
The use of phytoconstituents single or combined with standard medicines has been utilized in cure of different diseases. Many plants of genus Cordia comprise of trees and shrubs are widely distributed in warmer regions a...
VALIDATED COLORIMETRIC METHODS FOR THE ESTIMATION OF TENELIGLIPTIN IN TABLETS
Two simple sensitive and precise methods A and B were developed for the estimation of teneligliptin in bulk drug as well as in pharmaceutical dosage form. Method A is based on the formation of a red colored chromogen by...
BIOLOGICALLY ACTIVE PYRIMIDINE HYDARZONES
Pyrimidine constitutes an important class of heterocycles in drug discovery & is very well known for their anticancer, antimicrobial, antioxidant & antiviral activities. Hydrazones is a class of organic compounds with th...
SIMULTANEOUS STIMATION OF ASPIRIN AND OMEPRAZOLE (Y0SPRALA) IN BULK BY UV-SPECTROSCOPY
In India, there are roughly 30 million heart patients and two lakh surgeries are being performed every year. YOSPRALA-a new emerging drug approved by USFDA in September 2016 to treat Ischemic stroke, prophylaxis and gast...